Intervention

Rapastinel

ClinicalTrials.gov intervention label

Clinical trials11
Recruiting0
Common conditions1
Lead sponsors shown1

Clinical trials

11 shown
Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)NCT03855865 · 2019-07-01
WITHDRAWN
Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)NCT03675776 · 2018-10-30
TERMINATED
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)NCT03668600 · 2018-08-23
TERMINATED
Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)NCT03614156 · 2018-08-02
TERMINATED
Study of Rapastinel as Monotherapy in Patients With MDDNCT03560518 · 2018-06-15
TERMINATED
A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive DisorderNCT03352453 · 2017-12-15
TERMINATED
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderNCT03002077 · 2017-02-03
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderNCT02951988 · 2016-11-13
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)NCT02943577 · 2016-11-02
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)NCT02943564 · 2016-11-01
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)NCT02932943 · 2016-10-15
COMPLETED

Trial status mix

COMPLETED5
TERMINATED5
WITHDRAWN1

Phase mix

PHASE310
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.